[go: up one dir, main page]

AU2002221099A1 - Combination drugs - Google Patents

Combination drugs

Info

Publication number
AU2002221099A1
AU2002221099A1 AU2002221099A AU2109902A AU2002221099A1 AU 2002221099 A1 AU2002221099 A1 AU 2002221099A1 AU 2002221099 A AU2002221099 A AU 2002221099A AU 2109902 A AU2109902 A AU 2109902A AU 2002221099 A1 AU2002221099 A1 AU 2002221099A1
Authority
AU
Australia
Prior art keywords
combination drugs
drugs
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221099A
Inventor
Shohei Hashiguchi
Masayuki Ii
Yuji Iizawa
Tomoyuki Kitazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002221099A1 publication Critical patent/AU2002221099A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002221099A 2000-12-08 2001-12-07 Combination drugs Abandoned AU2002221099A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-379787 2000-12-08
JP2000379787 2000-12-08
PCT/JP2001/010773 WO2002045750A1 (en) 2000-12-08 2001-12-07 Combination drugs

Publications (1)

Publication Number Publication Date
AU2002221099A1 true AU2002221099A1 (en) 2002-06-18

Family

ID=18848088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221099A Abandoned AU2002221099A1 (en) 2000-12-08 2001-12-07 Combination drugs

Country Status (5)

Country Link
US (1) US20040063685A1 (en)
EP (1) EP1348443A4 (en)
AU (1) AU2002221099A1 (en)
CA (1) CA2431206C (en)
WO (1) WO2002045750A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003084527A1 (en) * 2002-04-08 2003-10-16 Takeda Chemical Industries, Ltd. Severe sepsis preventive therapeutic agent
BRPI0518829A2 (en) 2004-12-06 2008-12-09 Avigen Inc Method for the treatment of neuropathic pain and associated syndromes
US20080181876A1 (en) * 2007-01-30 2008-07-31 Johnson Kirk W Methods for treating acute and subchronic pain
US20080287402A1 (en) * 2007-05-03 2008-11-20 Johnson Kirk W Use of a glial attenuator to prevent amplified pain responses caused by glial priming
WO2009062132A2 (en) 2007-11-09 2009-05-14 California Institute Of Technology Immunomodulating compounds and related compositions and methods
CA2723689C (en) * 2008-05-05 2016-07-05 Ryan A. Shenvi Synthesis of (+) cortistatin a and related compounds
WO2010098906A1 (en) * 2009-02-24 2010-09-02 Madeira Therapeutics Liquid statin formulations
ME02364B (en) 2010-01-27 2016-06-20 Takeda Pharmaceuticals Co COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVOUS DRESS CAUSED BY A CANCER MEDICAMENT
EP2555753B1 (en) 2010-04-07 2018-08-01 California Institute of Technology Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
US20110287048A1 (en) 2010-05-20 2011-11-24 Round June L Antigen Specific Tregs and related compositions, methods and systems
WO2013086493A1 (en) * 2011-12-09 2013-06-13 The Children's Hospital Of Philadelphia Compositions and methods for the generation of activated protein c and methods of use thereof
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001639A1 (en) * 1989-08-01 1991-02-21 Scripps Clinic And Research Foundation Methods and compositions for ameliorating the symptoms of sepsis
GB8918232D0 (en) * 1989-08-10 1989-09-20 Opal Stephen M Pharmaceutical product for the treatment of septic shock
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
MX9700109A (en) * 1994-07-01 1997-04-30 Pro Neuron Inc Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis.
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
JP3693377B2 (en) * 1995-04-20 2005-09-07 森永乳業株式会社 Peptide mixture having infection-protecting action in vivo and composition containing this peptide mixture
ZA969721B (en) * 1995-11-21 1997-11-28 Smithkline Beecham Corp Method of treating sepsis.
US5753218A (en) * 1996-05-03 1998-05-19 Schering Corporation Method for treating inflammation
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
IL131042A0 (en) * 1997-02-03 2001-01-28 Pfizer Prod Inc Arylsulfonylamino hydroxamic acid derivatives
BR9908610A (en) * 1998-03-09 2000-12-05 Takeda Chemical Industries Ltd Compound, process to produce the same, pharmaceutical composition, use of the compound, processes to inhibit the production of nitric oxide and / or cytokine in mammals, and to prevent or treat heart disease, autoimmune disease or septic shock in mammals, and, for medications
AU6471200A (en) * 1999-08-06 2001-03-05 Takeda Chemical Industries Ltd. Substituted aromatic-ring compounds, process for producing the same, and use
KR100784752B1 (en) * 2000-02-04 2007-12-13 다케다 야쿠힌 고교 가부시키가이샤 Stable Emulsion Composition

Also Published As

Publication number Publication date
WO2002045750A1 (en) 2002-06-13
CA2431206A1 (en) 2002-06-13
CA2431206C (en) 2009-09-01
EP1348443A4 (en) 2005-07-06
EP1348443A1 (en) 2003-10-01
US20040063685A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2001288294A1 (en) Anti-hypercholesterolemic drug combination
AU6419701A (en) Electropancreatography
AU2001269508A1 (en) Drugs or cosmetics
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001258349A1 (en) Bisacylguanidine
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2002221099A1 (en) Combination drugs
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2001232244A1 (en) Drug comprising combination
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001272718A1 (en) Medicaments
AU2001292578A1 (en) Pharmaceutical compounds
AU2001260192A1 (en) Glycinamides
AU2001266201A1 (en) Medicaments
AU2000279374A1 (en) Secure syringe
AU2001256287A1 (en) 2-phenyl-2h-pyridazine-3-ones
AU2001256521A1 (en) Golf-putters
AU2002217467A1 (en) Combination drugs
AU2001267941A1 (en) Sailcraft